Literature DB >> 12525873

Comprehensive analysis of intestinal cytokine messenger RNA profile by real-time quantitative polymerase chain reaction in patients with inflammatory bowel disease.

Yoshinori Sawa1, Nobuhide Oshitani, Kenji Adachi, Kazuhide Higuchi, Takayuki Matsumoto, Tetsuo Arakawa.   

Abstract

Although the cytokine network plays a key role in the inflammatory responses in inflammatory bowel disease, no comprehensive analysis of the intestinal cytokine network has been reported. We analyzed messenger RNA levels for various cytokines in human intestine by real-time quantitative polymerase chain reaction to clarify the cytokine profiles involved in the pathogenesis of inflammatory bowel disease. Biopsy specimens were obtained from 23 patients with ulcerative colitis (15 men, 8 women, mean age of 44.1 years), 17 patients with Crohn's disease (15 men, 2 women, mean age of 21.6 years), and 8 normal controls (6 men, 2 women, mean age of 62.7 years) who underwent colonoscopy for suspected colonic disease. Messenger RNA was isolated from two biopsy samples and reverse-transcribed to obtain cDNA. Mucosal mRNA levels for IL-1beta, IL-2, IL-4, IL-5, IL-8, IL-10, IL-12p35, IL-12p40, IL-15, IFN-gamma and TNF-alpha were simultaneously analyzed by real-time quantitative polymerase chain reaction. In patients with active ulcerative colitis, IL-1beta, IL-4, IL-5, IL-8, IL-12p40, IFN-gamma and TNF-alpha mRNA levels were significantly higher than those in controls. In patients with active Crohn's disease, IL-1beta, IL-8, and IL-12p40 mRNA levels were significantly higher than those in controls. Mucosal level of IL-12p40 mRNA was significantly higher in patients with inactive Crohn's disease than in controls. Both Th1 and Th2 cytokine mRNA levels were increased in colonic mucosa of patients with ulcerative colitis suggesting the possibility that cellular and humoral immunity play roles in the pathogenesis of this disease. In patients with Crohn's disease, Th1 cytokine mRNA levels were increased in colonic mucosa, suggesting predominance of cellular immunity in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525873

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  13 in total

1.  Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn's disease.

Authors:  D Kawashima; N Oshitani; Y Jinno; K Watanabe; S Nakamura; K Higuchi; T Arakawa
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

2.  Suppression of proinflammatory cytokine production in macrophages by lansoprazole.

Authors:  Akinari Hinoki; Kazunori Yoshimura; Keiko Fujita; Masumi Akita; Rie Ikeda; Masabumi Nagashima; Masahiko Nomura; Akira Satomi
Journal:  Pediatr Surg Int       Date:  2006-11       Impact factor: 1.827

Review 3.  Role of the endothelium in inflammatory bowel diseases.

Authors:  Walter E Cromer; J Michael Mathis; Daniel N Granger; Ganta V Chaitanya; J Steven Alexander
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

4.  Plasma interleukin-18 reflects severity of ulcerative colitis.

Authors:  Alicja Wiercinska-Drapalo; Robert Flisiak; Jerzy Jaroszewicz; Danuta Prokopowicz
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

5.  Anti-inflammatory Activity of Mollugin on DSS-induced Colitis in Mice.

Authors:  Juan Li; Jin-Ling Zhang; Xue-Peng Gong; Meng Xiao; Yuan-Yuan Song; Hui-Fang Pi; Guang Du
Journal:  Curr Med Sci       Date:  2020-10-29

6.  Persistent and selective effects of inflammation on smooth muscle cell contractility in rat colitis.

Authors:  R W Wells; M G Blennerhassett
Journal:  Pflugers Arch       Date:  2004-04-24       Impact factor: 3.657

7.  Effect of traditional Chinese medicinal enemas on ulcerative colitis of rats.

Authors:  Song-Ming Guo; Hong-Bin Tong; Lian-Song Bai; Wei Yang
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

8.  Osteopontin: participation in inflammation or mucosal protection in inflammatory bowel diseases?

Authors:  Fengyuan Chen; Hongchun Liu; Qiang Shen; Shengzhong Yuan; Lin Xu; Xunquan Cai; Jingjing Lian; Shi-yao Chen
Journal:  Dig Dis Sci       Date:  2013-01-30       Impact factor: 3.199

9.  Epigallocatechin-3-gallate-induced inhibition of interleukin-6 release and adjustment of the regulatory T/T helper 17 cell balance in the treatment of colitis in mice.

Authors:  Zhenglei Xu; Cheng Wei; R U Zhang; Jun Yao; Dinguo Zhang; Lisheng Wang
Journal:  Exp Ther Med       Date:  2015-10-23       Impact factor: 2.447

10.  The production of interferon-gamma-inducible protein 10 by granulocytes and monocytes is associated with ulcerative colitis disease activity.

Authors:  Atsushi Noguchi; Kenji Watanabe; Shosaku Narumi; Hirokazu Yamagami; Yasuhiro Fujiwara; Kazuhide Higuchi; Nobuhide Oshitani; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2007-12-25       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.